Subscribe to RSS
DOI: 10.1055/a-1850-2169
The Relationship Between Baseline Cortisol Levels and Surgery Method of Primary Bilateral Macronodular Adrenal Hyperplasia
Abstract
Aim was to explore the associations between baseline cortisol levels and surgery method of primary bilateral macronodular adrenal hyperplasia (PBMAH). We retrospectively reviewed the clinical features and management of 30 patients (18 females and 12 males) who were diagnosed with PBMAH in our center between 2005 and 2019. Based on surgery method, we divided the patients into two groups: unilateral adrenalectomy (UA) group; and bilateral adrenalectomy (BA) group. Serum cortisol rhythm and 24-hour urinary free cortisol (UFC/24 h) levels were assayed using chemiluminescence method. Associations between baseline cortisol levels and BA were assessed using logistic regression. The predictive value of baseline cortisol levels for BA was calculated using receiver operating characteristic (ROC) curves. Twenty patients (66.7%) underwent UAs and ten patients (33.3%) underwent BAs. After adjusting for age, sex, BMI, SBP, and adrenal volume, the concentrations of baseline serum cortisol (8 AM, 4 PM, and 0 AM) and UFC/24 h were associated with bilateral adrenalectomy (all p<0.05). The area under the ROC curve based on 8 AM serum cortisol level model was larger than that in models based on 4 PM, 0 AM serum cortisol levels and UFC/24 h, but the differences were non-significant (all p>0.05). According to maximum Youden index criteria, the optimal cutoffs of 8 AM serum cortisol level and UFC were 26.89 μg/dl and 406.65 μg/24 h, respectively, for BA. The baseline cortisol levels are positively associated with BA. Increased levels of baseline cortisol levels may predict higher possibility of BA, which should be confirmed by prospective studies.
Key words
serum cortisol - 24-hour urinary free cortisol - surgery method - primary bilateral macronodular adrenal hyperplasiaPublication History
Received: 25 January 2022
Accepted after revision: 03 May 2022
Article published online:
13 June 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart,
Germany
-
References
- 1 Chevalier B, Vantyghem MC, Espiard S. Bilateral adrenal hyperplasia: pathogenesis and treatment. Biomedicines 2021; 9: 1397
- 2 Kirschner MA, Powell RD, Lipsett MB. Cushing’s syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J Clin Endocrinol Metab 1964; 24: 947-955
- 3 Espiard S, Drougat L, Libé R. et al. ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J Clin Endocrinol Metab 2015; 100: E926-E935
- 4 Bouys L, Chiodini I, Arlt W. et al. Update on primary bilateral macronodular adrenal hyperplasia (PBMAH). Endocrine 2021; 71: 595-603
- 5 Yamada Y, Sakaguchi K, Inoue T. et al. Preclinical Cushing’s syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of gluco- and mineralocorticoids. Intern Med 1997; 36: 628-632
- 6 Bourdeau I, D’Amour P, Hamet P. et al. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing’s syndrome. J Clin Endocrinol Metab 2001; 86: 5534-5540
- 7 Su HC, Dai J, Huang X. et al. Classification, diagnosis and treatment of ACTH-independent macronodular adrenal hyperplasia. Can Urol Assoc J 2013; 7: E594-E597
- 8 Doppman JL, Chrousos GP, Papanicolaou DA. et al. Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 2000; 216: 797-802
- 9 Ritzel K, Beuschlein F, Mickisch A. et al. Clinical review: outcome of bilateral adrenalectomy in Cushing’s syndrome: a systematic review. J Clin Endocrinol Metab 2013; 98: 3939-3948
- 10 Nieman LK, Biller BM, Findling JW. et al. Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2015; 100: 2807-2831
- 11 Guerin C, Taieb D, Treglia G. et al. Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?. Endocr Relat Cancer 2016; 23: R131-R142
- 12 Meloche-Dumas L, Mercier F, Lacroix A. Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab 2021; 35: 101486
- 13 Kaye DR, Storey BB, Pacak K. et al. Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol 2010; 184: 18-25
- 14 Zhang Y, Li H. Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease. Int J Clin Exp Med 2015; 8: 19311-19317
- 15 Lowery AJ, Seeliger B, Alesina PF. et al. Posterior retroperitoneoscopic adrenal surgery for clinical and subclinical Cushing’s syndrome in patients with bilateral adrenal disease. Langenbecks Arch Surg 2017; 402: 775-785
- 16 Lacroix A, Feelders RA, Stratakis CA. et al. Cushing’s syndrome. Lancet 2015; 386: 913-927
- 17 Lacroix A. ACTH-independent macronodular adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 2009; 23: 245-259
- 18 Di Dalmazi G, Reincke M. Adrenal surgery for Cushing’s syndrome: an update. Endocrinol Metab Clin North Am 2018; 47: 385-394
- 19 Yoshiaki TF, Srougi V, Almeida MQ. et al. A new insight into the surgical treatment of primary macronodular adrenal hyperplasia. J Endocr Soc. 2020 4. bvaa083
- 20 Nieman LK. Cushing’s syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol 2015; 173: M33-M38
- 21 Williams B, Mancia G, Spiering W. et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J 2018: 3021-3104
- 22 American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 2021; 44: S15-S33
- 23 Kanis JA, Melton LJ, Christiansen C. et al. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-1141
- 24 Dinnes J, Bancos I, Ferrante di Ruffano L. et al. Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis. Eur J Endocrinol 2016; 175: R51-R64
- 25 Lacroix A, Ndiaye N, Tremblay J. et al. Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome. Endocr Rev 2001; 22: 75-110
- 26 Lacroix A. Heredity and cortisol regulation in bilateral macronodular adrenal hyperplasia. N Engl J Med 2013; 369: 2147-2149
- 27 Albiger NM, Regazzo D, Rubin B. et al. A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype. Endocrine 2017; 55: 959-968
- 28 Duan L, Lu L, Lu Z. et al. [Clinical characteristics of adrenocorticotropic hormone independent macronodular adrenal hyperplasia: a report of 30 cases]. Zhonghua Yi Xue Za Zhi 2014; 94: 924-927
- 29 Libé R, Coste J, Guignat L. et al. Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing’s syndrome. Eur J Endocrinol 2010; 163: 129-138
- 30 Louiset E, Duparc C, Young J. et al. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med 2013; 369: 2115-2125
- 31 Shen WT, Lee J, Kebebew E. et al. Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg 2006; 141: 771-774 discussion 774–776
- 32 Storr HL, Mitchell H, Swords FM. et al. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing’s syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 2004; 61: 553-559
- 33 Debillon E, Velayoudom-Cephise FL, Salenave S. et al. Unilateral adrenalectomy as a first-line treatment of Cushing’s syndrome in patients with primary bilateral macronodular aAdrenal hyperplasia. J Clin Endocrinol Metab 2015; 100: 4417-4424
- 34 Sheikh-Ahmad M, Dickstein G, Matter I. et al. Unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia: analysis of 71 cases. Exp Clin Endocrinol Diabetes 2020; 128: 827-834
- 35 Iacobone M, Albiger N, Scaroni C. et al. The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH). World J Surg 2008; 32: 882-889
- 36 Albiger NM, Ceccato F, Zilio M. et al. An analysis of different therapeutic options in patients with Cushing’s syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience. Clin Endocrinol (Oxf) 2015; 82: 808-815
- 37 Osswald A, Quinkler M, Di Dalmazi G. et al. Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy. J Clin Endocrinol Metab 2019; 104: 2985-2993
- 38 Lamas C, Alfaro JJ, Lucas T. et al. Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: Long-term follow-up of four cases. Eur J Endocrinol 2002; 146: 237-240
- 39 Boronat M, Lucas T, Barceló B. et al. Cushing’s syndrome due to autonomous macronodular adrenal hyperplasia: long-term follow-up after unilateral adrenalectomy. Postgrad Med J 1996; 72: 614-616
- 40 Imöhl M, Köditz R, Stachon A. et al. [Catecholamine-dependent hereditary Cushing’s syndrome – follow-up after unilateral adrenalectomy]. Med Klin (Munich) 2002; 97: 747-753